Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
4
×
deals
4
×
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
4
×
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alzheimer's disease
cancer immunotherapy
johnson & johnson
merck
novartis
pfizer
aduro biotech
agenus
What
bio
4
×
drug
4
×
roundup
companies
nash
news
price
acquisitions
alzheimer’s
approval
approved
biggest
biogen’s
biopharmaceutical
build
buy
ceo
company’s
convo
daniel
debut
different
digital
disease
dyne’s
earlier
epidemic
fail
failures
fatty
fda
frenzied
gene
gilead
growing
increases
known
latest
led
littered
Language
unset
Current search:
cancer
×
bio
×
" san francisco blog main "
×
drug
×
deals
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More